0.1891
price down icon6.43%   -0.013
pre-market  Pre-mercato:  .19   0.0009   +0.48%
loading

Ernexa Therapeutics Inc Borsa (ERNA) Ultime notizie

pulisher
Apr 10, 2026

ERNA Should I Buy - Intellectia AI

Apr 10, 2026
pulisher
Apr 09, 2026

Is Ernexa Therapeutics Inc in a long term uptrend2026 Market Outlook & Accurate Entry and Exit Point Alerts - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 08, 2026

Institution Moves: Can Ernexa Therapeutics Inc continue delivering strong returns2026 Short Interest & Low Drawdown Trading Techniques - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 07, 2026

Analyst Calls: Is Ernexa Therapeutics Inc stock a good pick for beginners2026 Levels & Fast Moving Trade Plans - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 07, 2026

Signal Recap: Will Ernexa Therapeutics Inc outperform tech stocksPrice Action & AI Driven Stock Reports - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 05, 2026

Chart Watch: Will Ernexa Therapeutics Inc outperform tech stocks2026 Top Gainers & Precise Buy Zone Identification - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 04, 2026

ERNA PE Ratio & Valuation, Is ERNA Overvalued - Intellectia AI

Apr 04, 2026
pulisher
Apr 01, 2026

Ernexa Therapeutics (NASDAQ: ERNA) OKs Board-authorized 1-for-10–1-for-25 reverse split - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

ERNAW Technical Analysis | Trend, Signals & Chart Patterns | ERNEXA THERAPEUTICS INC31 (NASDAQ:ERNAW) - ChartMill

Apr 01, 2026
pulisher
Mar 31, 2026

ERNEXA THERAPEUTICS INC31 (ERNAW) Stock Chart - ChartMill

Mar 31, 2026
pulisher
Mar 31, 2026

Ernexa plans ovarian cancer trial for cell therapy ERNA-101 By Investing.com - Investing.com Canada

Mar 31, 2026
pulisher
Mar 31, 2026

Deep tumor regressions put Ernexa on track for 2026 human trial - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

ERNAW | Ernexa Therapeutics Inc. Warrants Insider Trading - Quiver Quantitative

Mar 31, 2026
pulisher
Mar 31, 2026

[EFFECT] Ernexa Therapeutics Inc. SEC Filing - Stock Titan

Mar 31, 2026
pulisher
Mar 30, 2026

Momentum Shift: Is Ernexa Therapeutics Inc a strong candidate for buy and holdLayoff News & Fast Exit and Entry Strategy Plans - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 21, 2026

Eterna Therapeutics Faces Nasdaq Delisting Risk After Notice - The Globe and Mail

Mar 21, 2026
pulisher
Mar 21, 2026

Ernexa Therapeutics Inc. Files Form 8-K: Notice of Nasdaq Delisting and Company Response – March 2026 - Minichart

Mar 21, 2026
pulisher
Mar 21, 2026

Ernexa Therapeutics receives Nasdaq delisting notice due to minimum bid price By Investing.com - Investing.com India

Mar 21, 2026
pulisher
Mar 20, 2026

Ernexa Therapeutics receives Nasdaq delisting notice due to minimum bid price - Investing.com Australia

Mar 20, 2026
pulisher
Mar 20, 2026

Ernexa Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Mar 20, 2026
pulisher
Mar 17, 2026

Resistance Check: Is PAVmed Inc stock a value trap2026 Key Lessons & Precise Buy Zone Tips - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

AI Stocks: Why is Ernexa Therapeutics Inc stock going upTrade Risk Report & High Conviction Buy Zone Alerts - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 16, 2026

Ernexa Therapeutics Inc may offer up to $50 million of securitiesSEC filing - marketscreener.com

Mar 16, 2026
pulisher
Mar 16, 2026

Ernexa Therapeutics IncMay Offer Up To $50 Million Of SecuritiesSEC Filing - TradingView

Mar 16, 2026
pulisher
Mar 14, 2026

Ernexa Therapeutics Inc. 2025 Annual Report: Synthetic Allogeneic iMSC Therapy, Business Overview, Key Risks, and Patent Portfolio - Minichart

Mar 14, 2026
pulisher
Mar 13, 2026

Ernexa Therapeutics 2025 10-K: $0.0M Revenue, Net Loss $(14.08)M - TradingView

Mar 13, 2026
pulisher
Mar 13, 2026

Ernexa Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 13, 2026
pulisher
Mar 13, 2026

Tranche Update on Ernexa Therapeutics Inc.'s Equity Buyback Plan announced on November 25, 2024. - marketscreener.com

Mar 13, 2026
pulisher
Mar 12, 2026

Aug Wrap: Is Ernexa Therapeutics Inc exposed to currency risksPortfolio Growth Summary & Technical Analysis for Trade Confirmation - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 12, 2026

Ernexa Therapeutics Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 12, 2026
pulisher
Mar 06, 2026

Aug Sentiment: What is Ernexa Therapeutics Incs book value per shareJuly 2025 Price Swings & Accurate Entry/Exit Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 05, 2026

Breakout Move: Is Ernexa Therapeutics Inc a strong candidate for buy and holdJuly 2025 Institutional & Pattern Based Trade Signal System - baoquankhu1.vn

Mar 05, 2026
pulisher
Mar 04, 2026

Ernexa Therapeutics Inc.Common Stock (NQ: ERNA - FinancialContent

Mar 04, 2026
pulisher
Mar 04, 2026

Comparing Aditxt (NASDAQ:ADTX) & Ernexa Therapeutics (NASDAQ:ERNA) - Defense World

Mar 04, 2026
pulisher
Feb 27, 2026

ERNA Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

Eterna Therapeutics Updates Investor Presentation, Highlights Web Disclosure - The Globe and Mail

Feb 27, 2026
pulisher
Feb 26, 2026

Ernexa Therapeutics updates investor presentation, posts Exhibit 99.1 on website - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Ernexa Therapeutics (NASDAQ: ERNA) furnishes new February 2026 investor presentation - Stock Titan

Feb 26, 2026
pulisher
Feb 24, 2026

Ernexa Therapeutics (NASDAQ:ERNA) Trading Down 11.4% – Time to Sell? - Defense World

Feb 24, 2026
pulisher
Feb 20, 2026

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series - GlobeNewswire

Feb 20, 2026
pulisher
Feb 20, 2026

Will Ernexa Therapeutics Inc. stock outperform value stocksQuarterly Growth Report & Fast Moving Stock Watchlists - mfd.ru

Feb 20, 2026
pulisher
Feb 18, 2026

Insider Stock Purchases: February 18, 2026 - Quiver Quantitative

Feb 18, 2026
pulisher
Feb 17, 2026

Ernexa therapeutics ten percent owner Cherington buys $2m in stock By Investing.com - Investing.com India

Feb 17, 2026
pulisher
Feb 17, 2026

Ernexa therapeutics ten percent owner Cherington buys $2m in stock - Investing.com

Feb 17, 2026
pulisher
Feb 16, 2026

ERNA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 16, 2026
pulisher
Feb 16, 2026

Will Ernexa Therapeutics Inc. outperform tech stocksJuly 2025 Chart Watch & Accurate Buy Signal Notifications - mfd.ru

Feb 16, 2026
pulisher
Feb 16, 2026

Can Ernexa Therapeutics Inc. continue delivering strong returnsQuarterly Trade Review & Capital Efficiency Focused Strategies - mfd.ru

Feb 16, 2026
pulisher
Feb 14, 2026

Will Ernexa Therapeutics Inc. stock remain a Wall Street favoriteWeekly Market Outlook & Short-Term High Return Ideas - mfd.ru

Feb 14, 2026
pulisher
Feb 12, 2026

Will Ernexa Therapeutics Inc. stock benefit from green energy trendsTrade Volume Summary & Accurate Buy Signal Notifications - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Eterna Therapeutics Completes Public Offering to Bolster Capital - TipRanks

Feb 11, 2026
pulisher
Feb 11, 2026

Ernexa Therapeutics Signs Multiple Financing Agreements - TradingView

Feb 11, 2026
pulisher
Feb 11, 2026

Profit Review: Can Ernexa Therapeutics Inc. be recession proofWeekly Gains Report & Daily Momentum Trading Reports - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

What hedge fund activity signals for Ernexa Therapeutics Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - mfd.ru

Feb 11, 2026
pulisher
Feb 08, 2026

Total debt of Ernexa Therapeutics Inc. – NASDAQ:ERNAW - TradingView

Feb 08, 2026
pulisher
Feb 06, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Feb 06, 2026
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
Capitalizzazione:     |  Volume (24 ore):